Test Price
700 AEDโ Home Collection Available
๐ Results in 3โ4 working days
Beta Thalassemia (9 Common Mutations) Screening
Executive Summary & Core Metrics
- Diagnostic Accuracy: 99.9% sensitivity via ISO 9001:2015 certified endpoint PCR protocol.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Medical Guidance: Post-result telephone consultation with a Consultant Medical Geneticist.
- Insurance: Direct coverage verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This DNA-based test screens for the 9 most prevalent beta-thalassemia mutations in the UAE population using endpoint PCR, providing definitive carrier or affected status within 3โ4 working days. It is the gold standard for carrier screening, preconception risk assessment, and prenatal genetic counseling.
| Parameter | Our Test (Beta Thalassemia 9 Common Mutations Screening) | Standard Hb Electrophoresis + CBC |
|---|---|---|
| Precision | Molecular detection of specific mutations (99.9% sensitivity) | Indirect hemoglobin pattern, may miss silent carriers |
| Method | Endpoint PCR (ISO 9001:2015 validated protocol) | HPLC / Capillary Electrophoresis |
| Speed | 3โ4 working days | 1โ2 working days |
| Clinical Use | Carrier screening, preconception, prenatal risk assessment | Initial anemia work-up, not definitive for carrier status |
Physician Insight & Safety Protocols
Consultant Medical Genetics Lina Osama Zaki Quteineh (DHA Registration: 9294403) advises: โThis PCR-based test provides definitive genetic answers, but it must be interpreted alongside a complete blood count and family history. A negative result for these 9 common mutations does not exclude rare variants; clinical correlation is essential.โ
Medication & Treatment Advisory
Medication Warning:
Do not discontinue any prescribed iron chelation therapy, folic acid, or blood transfusions without consulting your hematologist. This test is for screening and diagnosis only, not for treatment management.
Exclusion Criteria & Emergency Red Flags
- Recent blood transfusion within 12 weeks may lead to false-negative results due to donor DNA โ inform the lab.
- Patients on bone marrow transplantation should not undergo this PCR screening; chimerism analysis may be required.
- If you experience sudden severe anemia, jaundice, or abdominal swelling, seek immediate emergency care.
- For minors under 18 years, parental consent and valid identification are mandatory under Federal Decree-Law No. 4 of 2016 on Medical Liability.
Patient FAQ & Clinical Guidance
1. Who should get the Beta Thalassemia 9 Common Mutations Screening in the UAE?
Quick answer: Couples planning pregnancy, individuals with a family history of thalassemia, and anyone with unexplained microcytic anemia should consider this to determine carrier status or confirm diagnosis.
2. Is a doctor's prescription required for this test?
Quick answer: This test requires a valid prescription from a licensed physician. Pre-surgical, pregnancy, and health travel protocols may accept alternative referrals; please consult our team for guidance.
3. How long does it take to get results, and what does a positive result mean?
Quick answer: Results are ready within 3โ4 working days. A positive detection of a mutation indicates carrier or disease status, requiring genetic counseling and partner screening if planning pregnancy.
UAE Regulatory & Data Privacy Adherence
- Compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL)
- Adheres to Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields
- Clinical safety and patient consent in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability
- DHA Facility License Number: 1143
- ISO 9001:2015 Certification: INT/EGQ/2509DA/3139
- Laboratory Address: Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE
- Corporate Lab Branding: DNA Labs UAE
Clinical & Logistical Metadata
| Test Name | Beta Thalassemia (9 Common Mutations) Screening |
| Price (AED) | 700 AED |
| Turnaround Time | 3โ4 working days |
| Sample Type / Matrix | Peripheral whole blood |
| Methodology Used | Endpoint PCR (ISO 9001:2015 certified protocol) |
| ICD-10-CM Code | Z13.0 (Screening for carrier of thalassemia) |
| LOINC Code | 49519-1 (Beta globin gene mutations panel) |
| DHA Facility License & Laboratory Address | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
Preparation Required
["No specific fasting required", "Inform the lab about any recent blood transfusions (within 12 weeks)"]
Medically Reviewed by Dr. Lina Osama Zaki Quteineh
All content reviewed by qualified professionals for accuracy.
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians